Highlights

  • Elevate announced successful U-pgrade pilot plant results on 31 August 2026.
  • The company increased the Koppies project resource base to 76.2 million pounds in April.
  • Elevate reported a 31% increase to the Marenica uranium resource in June.
  • The company released its September-quarter activities and cash-flow report on 30 October.

Elevate Uranium Ltd (ASX:EL8) advanced two linked parts of its uranium strategy during 2026: resource development in Namibia and test work on its proprietary U-pgrade processing technology. The company released pilot plant results in August and its September Quarterly Report on 30 October, bringing technical and project updates into the same reporting period.

Resource Work and Processing Tests Converge

The company’s portfolio also includes Australian uranium interests, but the latest resource announcements have given its Namibian operations particular prominence.

Koppies and Marenica Extend the Resource Base

In April, Elevate announced an increase in the Koppies uranium project resource base to 76.2 million pounds. In June, it separately reported a 31% increase in the Marenica project resource. These refer to different project areas and should not be presented as interchangeable resource figures.

Elevate subsequently announced an increase in its ownership of the Marenica Uranium Project to 90%, with a sequence of July and August updates. The ownership changes and resource estimates address different aspects of the project’s development position.

Processing Work Adds a Technical Dimension

Elevate’s 31 August announcement reported successful results from its U-pgrade pilot plant programme. The process is part of the company’s approach to evaluating uranium recovery and potential Downstream project development. Pilot results are technical test outcomes, rather than evidence of full-scale commercial processing.

The company also released a World Nuclear Symposium presentation in September, providing a further account of its projects and technology. Koppies and Marenica remain central to the disclosed resource development activity, while the processing work forms an associated technical programme.

Outlook: Further Evaluation Before Development

Elevate’s near-term reporting focus includes follow-up technical studies, continued evaluation of its resource portfolio and the progression of U-pgrade technology. Project resources and pilot plant results provide information for later development decisions, but neither is a substitute for completed feasibility, funding and construction milestones.

The company’s October quarterly disclosure is the latest regular operating report identified before 6 November. Subsequent updates will determine how technical work and project studies advance towards any proposed development decision.

Elevate Uranium shares traded at AUD 0.215 on 6 November 2026, with a daily change of 0.00%. Trading Volume was 686,980 shares, with a session high of AUD 0.215 and low of AUD 0.195. Market Capitalisation was approximately AUD 102.61 million.